SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-176118
Filing Date
2012-04-23
Accepted
2012-04-23 17:00:31
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT d338841d10ka.htm 10-K/A 197393
2 SECTION 302 CEO CERTIFICATION d338841dex311.htm EX-31.1 2801
3 SECTION 302 CFO CERTIFICATION d338841dex312.htm EX-31.2 2673
4 SECTION 906 CEO CERTIFICATION d338841dex321.htm EX-32.1 4298
5 SECTION 906 CFO CERTIFICATION d338841dex322.htm EX-32.2 4292
  Complete submission text file 0001193125-12-176118.txt   212746
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31564 | Film No.: 12773804
SIC: 2834 Pharmaceutical Preparations